Galectin Therapeutics
(NASDAQ:GALT)
$2.10
-0.08[-3.67%]
At close: Aug 17
$2.18
0.0800[3.81%]
After Hours: 4:30PM EDT
Day High/Low2.08 - 2.19
52 Week High/Low1.19 - 2.57
Open / Close2.15 / -
Float / Outstanding- / 59.4M
Vol / Avg.38.6K / 94.5K
Mkt Cap124.7M
P/E-
50d Avg. Price1.7
Div / Yield-
Payout Ratio-
EPS-0.17
Total Float31.2M

Galectin Therapeutics (NASDAQ:GALT), Quotes and News Summary

Galectin Therapeutics (NASDAQ: GALT)

Day High/Low2.08 - 2.19
52 Week High/Low1.19 - 2.57
Open / Close2.15 / -
Float / Outstanding- / 59.4M
Vol / Avg.38.6K / 94.5K
Mkt Cap124.7M
P/E-
50d Avg. Price1.7
Div / Yield-
Payout Ratio-
EPS-0.17
Total Float31.2M
Sector: Health Care.Industry: Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-14
REV
Q2 2022Est.ActualSurprise
EPS-0.160
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Galectin Therapeutics Questions & Answers

Q
How do I buy Galectin Therapeutics (GALT) stock?
A

You can purchase shares of Galectin Therapeutics (NASDAQ: GALT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Galectin Therapeutics's (GALT) competitors?
Q
What is the target price for Galectin Therapeutics (GALT) stock?
A

The latest price target for Galectin Therapeutics (NASDAQ: GALT) was reported by HC Wainwright & Co. on Tuesday, May 17, 2022. The analyst firm set a price target for 11.00 expecting GALT to rise to within 12 months (a possible 423.81% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Galectin Therapeutics (GALT)?
A

The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.1 last updated Today at August 17, 2022, 7:57 PM UTC.

Q
Does Galectin Therapeutics (GALT) pay a dividend?
A

There are no upcoming dividends for Galectin Therapeutics.

Q
When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?
A

Galectin Therapeutics’s Q3 earnings are confirmed for Monday, November 14, 2022.

Q
Is Galectin Therapeutics (GALT) going to split?
A

There is no upcoming split for Galectin Therapeutics.

Q
What sector and industry does Galectin Therapeutics (GALT) operate in?
A

Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.